icone plus
Contact Abonnez-vous aux actualités
Reason for request
Re-assessment of Actual Benefit in compliance with article R. 163-21 of the French Social Security Code.
Clinical Benefit
Insufficient
The Committee considers that the actual benefit of AVANDIA and AVANDAMET products is now insufficient for it to be paid for by National Health Insurance, in comparison with existing therapies.
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
8XPzEFBpRQmneHJ7
Listen
